LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug TST003 tested in patients with advanced cancers
Disease control OngoingThis early-stage study tests a new drug called TST003 in about 111 adults with advanced solid tumors (cancers that have spread or cannot be removed by surgery). The main goals are to find a safe dose, check side effects, and see if the drug can shrink tumors. Participants receive…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New IL-2 drug aims to supercharge immune attack on Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug called TransCon IL-2 β/γ, which is designed to boost the immune system's ability to fight advanced solid tumors. About 320 adults with cancers like ovarian, melanoma, lung, or cervical cancer will receive the drug alone or combined with other…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated May 17, 2026 04:14 UTC